Clinical Trial Update: Safety of Interferon Gamma-1b With Rituximab in Non-Hodgkin's Lymphoma Patients [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/Phase 2 trials evaluated the safety of combining interferon gamma-1b with rituximab in patients with non-Hodgkin's lymphoma; the study was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• ACTIMMUNE (interferon gamma-1b)
• Rituxan (rituximab)

Snippet

Sponsor: InterMune | Conditions: Non-Hodgkin's Lymphoma | Phase 1, Phase 2 | Status: TERMINATED